Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losec for Iron Absorption in CDAI
NCT01795794Phase 4Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Apr 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of omeprazole in Congenital dyserythropoietic anemia type I, sponsored by Soroka University Medical Center. Primary endpoints: Number of adverse effects at 1 year, Iron levels at 12 months and 1 more. Status: unknown.
02
Drugs
omeprazole
03
Conditions
Congenital dyserythropoietic anemia type I
Beyond the preview
Go deeper on NCT01795794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795794.